These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36806884)

  • 1. Premise, promise and challenges of MDMA assisted therapy for PTSD.
    Madero S; Alvarez OD
    Eur Neuropsychopharmacol; 2023 May; 70():19-20. PubMed ID: 36806884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic investigation with MDMA (ecstasy)].
    Bouso Saiz JC; Gómez-Jarabo G
    Med Clin (Barc); 2003 Sep; 121(8):318; author reply 318-9. PubMed ID: 14499096
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
    Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
    J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA to Treat PTSD in Adults.
    Latimer D; Stocker MD; Sayers K; Green J; Kaye AM; Abd-Elsayed A; Cornett EM; Kaye AD; Varrassi G; Viswanath O; Urits I
    Psychopharmacol Bull; 2021 Jun; 51(3):125-149. PubMed ID: 34421149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and promise for the MDMA drug development program.
    Feduccia AA; Holland J; Mithoefer MC
    Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The re-emergence of hallucinogenic research.
    Begola MJ; Dowben JS
    Perspect Psychiatr Care; 2018 Oct; 54(4):523-526. PubMed ID: 29464720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
    Bouso JC; Doblin R; Farré M; Alcázar MA; Gómez-Jarabo G
    J Psychoactive Drugs; 2008 Sep; 40(3):225-36. PubMed ID: 19004414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
    Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R
    PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD.
    Brewerton TD; Lafrance A; Mithoefer MC
    Med Hypotheses; 2021 Jan; 146():110367. PubMed ID: 33203569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Field of Psychedelic Psychotherapy.
    Barber GS; Aaronson ST
    Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecstasy (MDMA) dependence.
    Jansen KL
    Drug Alcohol Depend; 1999 Jan; 53(2):121-4. PubMed ID: 10080038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
    Smith KW; Sicignano DJ; Hernandez AV; White CM
    J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
    Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why MDMA therapy for alcohol use disorder? And why now?
    Sessa B
    Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research on psychedelics moves into the mainstream.
    Morris K
    Lancet; 2008 May; 371(9623):1491-2. PubMed ID: 18459186
    [No Abstract]   [Full Text] [Related]  

  • 16. Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review.
    Szafoni S; Więckiewicz G; Pudlo R; Gorczyca P; Piegza M
    Psychiatr Pol; 2022 Aug; 56(4):823-836. PubMed ID: 37074831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of potential psychedelic treatments for PTSD.
    Henner RL; Keshavan MS; Hill KP
    J Neurol Sci; 2022 Aug; 439():120302. PubMed ID: 35700643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
    Feduccia AA; Mithoefer MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):221-228. PubMed ID: 29524515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.
    Ponte L; Jerome L; Hamilton S; Mithoefer MC; Yazar-Klosinski BB; Vermetten E; Feduccia AA
    J Trauma Stress; 2021 Aug; 34(4):851-863. PubMed ID: 34114250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA and PTSD treatment: "PTSD: From novel pathophysiology to innovative therapeutics".
    Sessa B
    Neurosci Lett; 2017 May; 649():176-180. PubMed ID: 27394687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.